Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 15,444 | 20,094 | 21,848 | 24,078 | 18,755 |
| Cost of Goods | 15,053 | 18,377 | 19,544 | 21,668 | 17,649 |
| Gross Profit | 391 | 1,717 | 2,304 | 2,410 | 1,106 |
| Operating Expenses | 890 | 966 | 888 | 1,043 | 1,085 |
| Operating Income | -500 | 751 | 1,416 | 1,367 | 21 |
| Other Income | 322 | 256 | -88 | -230 | -61 |
| Pre-tax Income | -178 | 1,007 | 1,329 | 1,137 | -41 |
| Income Tax | -78 | 470 | 522 | 465 | -15 |
| Net Income Continuous | -100 | 537 | 806 | 672 | -26 |
| Net Income | $-100 | $537 | $806 | $672 | $-26 |
| EPS Basic Total Ops | -0.01 | 0.03 | 0.05 | 0.04 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.03 | 0.05 | 0.04 | 0.00 |
| EPS Diluted Total Ops | -0.01 | 0.03 | 0.04 | 0.04 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.03 | 0.04 | 0.04 | 0.00 |
| EBITDA(a) | $490 | $1,717 | $2,304 | $2,410 | $1,106 |